DSS, INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
DSS$0.50+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the year ended December 31,2025 | For the year ended December 31,2024 | |
|---|---|---|
| Revenue: | ||
| Printed products | $18,085,000 | $16,107,000 |
| Rental | 1,236,000 | 1,792,000 |
| Commercial lending | 45,000 | 226,000 |
| Commission | 1,353,000 | 972,000 |
| Biotechnology | 38,000 | - |
| Total revenue | 20,757,000 | 19,097,000 |
| Costs and expenses: | ||
| Cost of revenue | 22,926,000 | 23,539,000 |
| Selling, general and administrative (including stock-based compensation) | 12,265,000 | 38,154,000 |
| Total costs and expenses | 35,191,000 | 61,693,000 |
| Operating loss | (14,434,000) | (42,596,000) |
| Other income (expense): | ||
| Interest income | 19,000 | 238,000 |
| Interest income on note receivable, related party | 32,000 | 102,000 |
| Dividend income | 20,000 | - |
| Other | 11,000 | 218,000 |
| Interest expense | (266,000) | (283,000) |
| Foreign Currency Translation Adjustment | - | (6,000) |
| Gain on extinguishment of debt | 595,000 | - |
| (Loss)/gain on equity method investment | (16,000) | 1,000 |
| (Loss) gain on investments | (807,000) | 224,000 |
| Impairment of investment | - | (782,000) |
| Impairment of intangible assets | (600,000) | - |
| Impairment of real estate assets | (2,420,000) | (7,288,000) |
| Provision for loan losses | - | (3,691,000) |
| (Loss)/gain on sale real estate assets | (9,622,000) | 165,000 |
| Loss from operations before income taxes | (27,488,000) | (53,698,000) |
| Income tax benefit | - | (8,000) |
| Net loss | $(27,488,000) | $(53,706,000) |
| Loss from operations attributed to noncontrolling interest | 3,559,000 | 6,810,000 |
| Net loss attributable to DSS common stockholders | $(23,929,000) | $(46,896,000) |
| Loss per common share attributable to common stockholders | ||
| Basic | $(2.66) | $(6.63) |
| Diluted | $(2.66) | $(6.63) |
| Shares used in computing loss per common share: | ||
| Basic | 8,991,425 | 7,072,377 |
| Diluted | 8,991,425 | 7,702,377 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.